RTI CEO to Speak at Fog World Congress 2017 SUNNYVALE,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
488
RTI CEO to Speak at Fog World Congress 2017

SUNNYVALE, CA--(Marketwired - Oct 24, 2017) - Real-Time Innovations (RTI), the Industrial Internet of Things (IoT) connectivity company, today announced that Chief Executive Officer, Dr. Stan Schneider, will be speaking at the OpenFog Consortium's Fog World Congress addressing key technical challenges across the IIoT. RTI joined the OpenFog Consortium as an early member in 2016, and Dr. Schneider serves as a chair on the conference's keynote committee.

Schneider will help kick off the conference by introducing keynote speaker, Jan Becker, CEO and co-founder of Apex.AI. In his keynote session titled, "Autonomous Driving: From Research to Product Development," Becker will discuss how the development of connected and autonomous vehicles intersects with many of the ongoing efforts of the fog computing community.

On the final day of the conference, Schneider will participate in a panel titled, "Fog Software and Software Infrastructure." Alongside industry experts from ClearBlade, GE Digital and SAP Labs, Schneider will address a number of key issues around building and deploying software and software infrastructure in support of large, complex fog applications. This panel of experts will also explain the difference between the cloud and the edge, and discuss security, standards and interoperability in regard to fog computing.

Immediately following, Schneider will participate in a panel titled, "V2X: Advancements in Vehicle Communications Technologies." Schneider will join industry leaders from ETSI MEC and the OpenFog Consortium to discuss V2X (Vehicle to Everything Connectivity) across consumer and commercial vehicles and transportation systems, and how vehicle-to-cloud solutions using a fog computing architecture support will enable autonomous driving.

Fog World Congress is a three-day, multitrack conference that will take place Oct. 30-Nov. 1, 2017 at the Santa Clara Marriott. Fog World Congress is the first conference that brings together industry and research to explore the technologies, challenges, industry deployments and opportunities in fog computing and networking.

RTI will also be exhibiting at the event in Booth #306. Additional details can be found below.

Event Details What: Fog World Congress 2017 When: Keynote Introduction: Mon., Oct. 30, 2017 at 2:25 p.m. PT Fog Software Panel: Weds., Nov. 1, 2017 from 10:30-11:20 a.m. PT Vehicle Communications Panel: Wed., Nov. 1, 2017 from 11:20 a.m.-12:10 p.m. PT Where: Santa Clara Marriott, 2700 Mission College Blvd., Santa Clara, CA, 95054; Booth #306

For additional information and a full conference agenda, please visit: http://bit.ly/2s2ympN

About RTI Real-Time Innovations (RTI) is the Industrial Internet of Things (IIoT) connectivity company. The RTI Connext® databus is a software framework that shares information in real time, making applications work together as one, integrated system. It connects across field, fog and cloud. Its reliability, security, performance and scalability are proven in the most demanding industrial systems. Deployed systems include medical devices and imaging; wind, hydro and solar power; autonomous planes, trains and cars; traffic control; Oil and Gas; robotics, ships and defense.

RTI lives at the intersection of functional artificial intelligence and pervasive networking(SM).

RTI is the largest vendor of products based on the Object Management Group (OMG) Data Distribution Service™ (DDS) standard. RTI is privately held and headquartered in Sunnyvale, Calif.

RTI is hiring aggressively; see www.rti.com/careers .

Media Contacts: Emily Singer Karbo Communications for RTI 415-255-6506 RTI@karbocom.com Cameron Smead Public Relations Senior Manager, RTI cameron@rti.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 188

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 384

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 260

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 267

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 392

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 382

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 371

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 472

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 344

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 433

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
/news?page=2">More News Articles